You might have noticed that things have changed on pharmaphorum recently, with the launch of our new website, so Paul Tunnah muses this month on some of the key changes... Read more
As our market access month continues and pharma seeks closer patient engagement to better understand real-world outcomes, Carly Brown outlines a number of ways to conduct patient research and weighs... Read more
In our market access themed month, Sophia Tickell comments on the reimbursement landscape in healthcare across Europe.
For decades, Europe's labs and R&D centres produced world-beating innovation. A different innovation of... Read more
Sam Olsen warns that the greatest threat to Pharmaceutical and Biotech corporate Intellectual Property (IP) security comes from within. He says that that companies should not just consider if their... Read more